结论卡巴拉汀和多奈哌齐可显著改善AD患者的认知功能、痴呆程度和日常生活能力，疗效相当，较为安全，耐受性好。
ConclusionRivastigmine and donepezil both similarly improve cognition, dementia degree and daily living ability in AD patients with generally good toleration and safety.
结论卡巴拉汀和多奈哌齐可显著改善AD患者的认知功能、痴呆程度和日常生活能力，疗效相当，较为安全，耐受性好。
ConclusionRivastigmine and donepezil both similarly improve cognition, dementia degree and daily living ability in AD patients with generally good toleration and safety.
应用推荐